Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Sep 1, 2026
Pulsed Electric Field Ablation Reprograms Tumor Immunity and Stimulates Germinal Center Formation in Tertiary Lymphoid Structures in Patients with Non-Small Cell Lung Cancer.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Multi-omics analysis reveals comprehensive aberrant protein and phosphorylation characteristics in breast cancer and paired metastatic lymph nodes.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Energy Balance-Related Factors and Direct Tumor-Adipocyte Contact in Colorectal Cancer: Etiologic Insights from the Population-Based Netherlands Cohort Study.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Intratumoral Sotigalimab with Pembrolizumab Induces Rapid Activation of Antigen-Presenting Cells and Drives Antitumor Responses in Non-injected Tumors in Metastatic Melanoma: A Phase I/II Study.
Read at PubMed CentralPubMed Central · Sep 1, 2026
PiggyBac-Engineered Membrane-Bound IL7 TILs Combined with Anti-PD-1 Antibody Demonstrates Efficacy in Recurrent Ovarian Cancer: A First-in-Human Phase I Trial.
Read at PubMed CentralPubMed Central · Sep 1, 2026
The Clinical Application of Refined Risk Estimates Study in BRCA1 and BRCA2 Pathogenic Variant Carriers: A Randomized Controlled Trial.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Sequential Immune Activation of Effector T Cells as Biomarkers of Response to Durvalumab in Patients with Locally Advanced NSCLC.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Development of the cf-MMSP Assay for Enhanced Analytical Sensitivity of Methylated DNA in Breast Cancer Liquid Biopsy.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Spatial Integration of Protein and Chromosomal States Reveals Early Copy-Number Changes and Genotype-Associated Immune Neighborhoods in Serous Ovarian Cancer Evolution.
Read at PubMed CentralPubMed Central · Sep 1, 2026
HRDetect in Tubo-ovarian Carcinoma: Stratification and Therapeutic Implications.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Phase Ib Trial of Bavdegalutamide (ARV-110) in Combination with Abiraterone for Metastatic Prostate Cancer.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Breast cancer mortality by age and race and/or ethnicity across counties in the United States, 2000-2019.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Efficacy and Genomic Analysis of HER2-Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial.
Read at PubMed CentralPubMed Central · Sep 1, 2026
A Multistate Survival Model to Identify Risk Factors for Lethal Ovarian Cancer.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Cellular Neighborhoods Govern Antitumor T-cell Infiltration Following Anti-CTLA-4 in Melanoma with Primary Resistance to Anti-PD-1.
Read at PubMed CentralPubMed Central · Sep 1, 2026
The burden of male breast cancer (MBC) in the GBD Central, Eastern, and Western Europe Regions from 1990 to 2023: Results from the Global Burden of Disease Study 2023.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Clinical evaluation using first-day assessment of patient suitability for successful performance of deep inspiration breath-hold for breast cancer radiotherapy.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Threshold association analysis between residual tumour size and distant metastasis risk after neoadjuvant therapy for rectal cancer: A multicentre retrospective study.
Read at PubMed CentralPubMed Central · Sep 1, 2026
Dietary-Derived Corchorus olitorius L. Extract Suppresses KRAS-Mutant Pancreatic Cancer by Activating Ferritinophagy-Dependent Ferroptosis.
Read at PubMed Central